For a mini-review published in the journal Particle and Fibre Technology in 2021, scientists wanted to evaluate whether Ti02 particles contributed to the development and/or exacerbation of irritable bowel disease, and whether they altered the four elements of intestinal barrier function: the intestinal microbiota, the immune system, the mucus layer, and the epithelium. The breakdown of these four elements can contribute to autoimmune, neurological, inflammatory, infectious, and metabolic diseases. Following their review, the researchers concluded: “Data indicate that TiO2 is able to alter the four compartments of IBF and to induce a low-grade intestinal inflammation associated or not with pre-neoplastic lesions.” 

The landscape for anatase titanium dioxide manufacturers is evolving rapidly, driven by technological advancements and a shift towards sustainability. As industries continue to recognize the unique properties and benefits of anatase TiO2, the demand for high-quality products is expected to grow. Manufacturers that can innovate and adapt to changing market needs while maintaining environmental responsibility will emerge as leaders in this dynamic sector. The future of anatase titanium dioxide is bright, with promising opportunities across various industries committed to harnessing its potential for a greener future.

Lithopone, an alternative to titanium dioxide